Clinical Trials · NCT05303857
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Enrollment
- 107
- Start date
- Mar 2022
- Locations
- 1 site, Germany
- Primary endpoint
- Central (aortic) pulse pressure assessed by Sphygmocor XCEL